Ocugen (OCGN) Enterprise Value (2014 - 2025)
Ocugen (OCGN) reported Enterprise Value of -$37.8 million for Q1 2025, down 43.18% on a YoY basis from -$66.5 million in Q1 2024, and down 140.81% quarter-over-quarter from -$15.7 million in Q2 2024.
Ocugen (OCGN) Enterprise Value (2014 - 2025) Analysis & Trends
Ocugen has reported Enterprise Value for 12 years, with the latest figure at -$37.8 million in Q1 2025.
- For the quarter ending Q1 2025, Enterprise Value fell 43.18% year-over-year to -$37.8 million; the trailing twelve-month figure through Mar 2025 stood at -$37.8 million (down 43.18% YoY), and the FY2023 full-year result was -$39.5 million, up 56.6% from the prior year.
- Enterprise Value for Q1 2025 stood at -$37.8 million, down from -$15.7 million in the prior quarter.
- The five-year high for Enterprise Value was -$15.7 million in Q2 2024, with the low at -$129.8 million in Q1 2022.
- Historically, Enterprise Value has averaged -$74.7 million across 5 years, with a median of -$76.7 million in 2023.
- Annual changes were most pronounced in 2021 — Enterprise Value slumped 1302.82% — and 2024, when it jumped 77.76%.
- Ocugen's Enterprise Value stood at -$95.0 million in 2021, then climbed by 4.24% to -$90.9 million in 2022, then jumped by 56.6% to -$39.5 million in 2023, then soared by 60.22% to -$15.7 million in 2024, then slumped by 140.81% to -$37.8 million in 2025.
- The last three Enterprise Value figures came in at -$37.8 million (Q1 2025), -$15.7 million (Q2 2024), and -$26.4 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -37.80 Mn |
| Jun 30, 2024 | -15.70 Mn |
| Mar 31, 2024 | -26.40 Mn |
| Dec 31, 2023 | -39.46 Mn |
| Sep 30, 2023 | -53.48 Mn |
| Jun 30, 2023 | -70.58 Mn |
| Mar 31, 2023 | -76.72 Mn |
| Dec 31, 2022 | -90.93 Mn |
| Sep 30, 2022 | -101.60 Mn |
| Jun 30, 2022 | -115.01 Mn |
| Mar 31, 2022 | -129.77 Mn |
| Dec 31, 2021 | -94.96 Mn |
| Sep 30, 2021 | -107.35 Mn |
| Jun 30, 2021 | -115.64 Mn |
| Mar 31, 2021 | -44.79 Mn |
| Dec 31, 2020 | -24.04 Mn |
| Sep 30, 2020 | -19.11 Mn |
| Jun 30, 2020 | -14.97 Mn |
| Mar 31, 2020 | -3.19 Mn |
| Dec 31, 2019 | -7.44 Mn |